Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd.’s Net Profit Rose 20.4% in First Quarter of 2023

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. (通化金马药业集团股份有限公司) (000766.SZ) reported a net profit of 6.7 million yuan in the first quarter of 2023, up 20.4% year-on-year.

Meanwhile, the company posted 308.6 million yuan in revenue, down 13.7% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 47.2%.